Cargando…
Ziconotide: Indications, Adverse Effects, and Limitations in Managing Refractory Chronic Pain
Autores principales: | Nair, Abhijit S., Poornachand, Anne, Kodisharapu, Praveen Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801619/ https://www.ncbi.nlm.nih.gov/pubmed/29440821 http://dx.doi.org/10.4103/IJPC.IJPC_113_17 |
Ejemplares similares
-
Nanotechnology in pain medicine: What is new?
por: Nair, Abhijit, et al.
Publicado: (2022) -
Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
por: Nair, Abhijit S., et al.
Publicado: (2021) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016) -
Lateral habenula: Significance in pain and depression
por: Nair, Abhijit, et al.
Publicado: (2022)